论文部分内容阅读
目的研究讨论阿托伐他汀治疗脑梗塞,对患者血脂、颈动脉粥样斑块的影响作用。方法选取我院2014年12月-2016年12月收治的脑梗塞患者64例为研究对象,按治疗方法分成研究组(n=32)和对照组(n=32)。研究组采用阿托伐他汀治疗,而对照组进行常规健康治疗,分别比较两组脑梗塞患者血脂水平和颈动脉粥样斑块变化情况。结果研究组患者治疗半年后的颈动脉粥样斑块体积减小明显,与对照组比较有显著差异性(P<0.05);治疗后两组患者的血脂水平差异有统计学意义(P<0.05)。结论脑梗塞患者采用阿托伐他汀后颈动脉粥样斑块体积明显减小,且血脂水平得到明显改善。
Objective To study the effect of atorvastatin on cerebral blood lipids and carotid artery plaque in patients with cerebral infarction. Methods Sixty-four patients with cerebral infarction who were treated in our hospital from December 2014 to December 2016 were selected as the research object and divided into the treatment group (n = 32) and the control group (n = 32). The study group was treated with atorvastatin, while the control group was given routine health treatment. The levels of blood lipid and carotid artery atherosclerotic plaque in two groups were compared. Results The carotid artery atherosclerotic plaque volume in the study group decreased significantly after six months of treatment, which was significantly different from the control group (P <0.05). There was significant difference in the level of blood lipid between the two groups after treatment (P <0.05 ). Conclusions The volume of carotid atherosclerotic plaque in patients with cerebral infarction was significantly reduced after atorvastatin treatment, and the blood lipid level was significantly improved.